It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The peroxisome is a versatile organelle that performs diverse metabolic functions. PEX3, a critical regulator of the peroxisome, participates in various biological processes associated with the peroxisome. Whether PEX3 is involved in peroxisome-related redox homeostasis and myocardial regenerative repair remains elusive. We investigate that cardiomyocyte-specific PEX3 knockout (Pex3-KO) results in an imbalance of redox homeostasis and disrupts the endogenous proliferation/development at different times and spatial locations. Using Pex3-KO mice and myocardium-targeted intervention approaches, the effects of PEX3 on myocardial regenerative repair during both physiological and pathological stages are explored. Mechanistically, lipid metabolomics reveals that PEX3 promotes myocardial regenerative repair by affecting plasmalogen metabolism. Further, we find that PEX3-regulated plasmalogen activates the AKT/GSK3β signaling pathway via the plasma membrane localization of ITGB3. Our study indicates that PEX3 may represent a novel therapeutic target for myocardial regenerative repair following injury.
The authors show that PEX3, as an essential regulator of peroxisome-related functions, promote myocardial regenerative repair through plasmalogen metabolism, facilitating plasma membrane localization of ITGB3 and activating the AKT/GSK3β signaling pathway.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 The First Affiliated Hospital of Nanjing Medical University, Department of Cardiology, Nanjing, China (GRID:grid.412676.0) (ISNI:0000 0004 1799 0784)
2 Nanjing Medical University, Key Laboratory of Cardiovascular and Cerebrovascular Medicine, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)
3 Nanjing Medical University, State Key Laboratory of Reproductive Medicine, School of Public Health, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)
4 Nanjing Medical University, Department of Biostatistics, School of Public Health, China International Cooperation Center for Environment and Human Health, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)
5 Nanjing Medical University, State Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)